CEACAM5 (Protein | Antibody | cDNA Clone | ELISA Kit)

All CEACAM5 reagents are produced in house and quality controlled, including 17 CEACAM5 Antibody, 1 CEACAM5 ELISA, 13 CEACAM5 Gene, 3 CEACAM5 Lysate, 5 CEACAM5 Protein, 1 CEACAM5 qPCR. All CEACAM5 reagents are ready to use.

CEACAM5 Protein (5)

CEACAM5 Antibody (17)

CEACAM5 ELISA Kit & Match Antibody ELISA Pair Set ( 1 )

CEACAM5 cDNA Clone (13)

NM_004363.2

CEACAM5 qPCR Primer (1)

CEACAM5 Lysate (3)

More Product Popular With Customers

CEACAM5 Background

CEACAM5, also known as CEA or D66e, belongs to the large CEACAM subfamily of immunoglobulin superfamily. CEACAM5 is expressed primarily by epithelial cells, and is synthesized as a glycoprotein with a MW of 18 kDa comprising 6% carbohydrate. CEACAM5 contains one Ig-like V-type domain at the N-terminus, followed by six Ig-like C2-type domain and a GPI anchor, and exists as a homodimer. CEACAM5 and CEACAM6 are overexpressed in many cancers and are associated with adhesion and invasion. CEACAM5 can mediate cell-cell adhesion through homotypic and heterotypic interactions. It functions as a homotypic intercellular adhesion molecule and serves as a widely used tumor marker, since it is expressed at higher levels in tumorous tissues than in corresponding normal tissues. CEACAM5 has also been shown to contribute to tumorigenicity by inhibiting cellular differentiation. In addition, CEACAM5 is identified as the host receptor for the Dr family of adhesins of E.Coli, and the binding of E.coli Dr adhesins leads to dissociation of the CEACAM5 homodimer.Immune CheckpointImmunotherapyCancer ImmunotherapyTargeted Therapy

CEACAM5 References

  • Baczyska D, et al. (2003) The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression. Cell Mol Biol Lett. 8(2): 471-86.
  • Blumenthal RD, et al. (2005) Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Cancer Res. 65(19): 8809-17.
  • Liebig B, et al. (2005) Forced expression of deltaN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin. Cancer Lett. 223(1): 159-67.